Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENTRY: Dapagliflozin in Prediabetic Stable CAD
NCT04330079Phase 4Terminated
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in coronary artery disease (CAD), prediabetes. Started May 2020; status: terminated.
02
Drugs
dapagliflozin
03
Conditions
coronary artery disease (CAD)prediabetes
Beyond the preview
Go deeper on NCT04330079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04330079.